MCUJFOTCPharmaceutical PreparationsFiscal year ends December 31

MEDICURE INC

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 24, 2026

$3.10+0.12 (+4.07%)

Close on Oct 19, 2026

MEDICURE INC balance sheet

Annual Quarterly

CAD USD

Millions of CAD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31
Cash & Equivalents	3.84	7.19	6.37	4.86	3.69	2.72	13	24	5.26	12	3.57	0.49
Cash & Short-Term Investments	3.84	7.19	6.37	4.86	3.69	2.72	13	24	5.26	12	3.57	0.49
Receivables	4.82	5.30	4.79	5.64	4.66	5.25	10	11	8.59	17	–	–
Inventory	2.94	3.28	2.90	3.22	3.33	5.14	6.33	4.24	3.08	12	–	–
Total Current Assets	12	16	15	15	13	16	31	90	115	55	–	–
Property, Plant & Equipment	0.95	0.96	0.74	1.19	1.61	1.64	1.28	0.32	0.22	10	–	–
Goodwill	4.26	3.38	3.10	3.18	2.97	2.99	0	–	–	47	–	–
Intangible Assets	7.75	9.35	8.94	11	11	14	9.60	1.71	1.76	101	–	–
Deferred Tax Assets	–	–	–	–	–	–	0	0.13	0.33	0.70	–	–
Other Long-Term Assets	0.11	0.10	0.08	0.06	0.06	0.16	0.04	0.12	–	0.16	–	–
Total Assets	25	30	28	30	28	34	42	104	129	215	–	–
Accounts Payable	11	7.93	7.60	7.13	6.67	6.98	9.38	14	10	18	–	–
Short-Term Debt	–	–	–	–	–	–	–	–	–	1.38	–	–
Current Portion of Long-Term Debt	–	–	–	–	–	–	–	–	–	2.88	–	–
Current Debt	–	–	–	–	–	–	–	–	–	4.27	–	–
Current Portion of Leases	0.46	0.37	0.32	0.35	0.38	0.37	0.24	–	–	–	–	–
Current Income Taxes Payable	0.09	0.10	0.02	0.06	0.11	0.16	0.52	1.06	2.43	0.50	–	–
Total Current Liabilities	12	8.40	7.93	8.39	8.51	12	12	17	44	62	–	–
Long-Term Debt	–	–	–	–	–	–	–	–	–	68	–	–
Long-Term Leases	0.43	0.51	0.23	0.50	0.79	1.08	0.85	–	–	–	–	–
Operating Lease Liabilities	0.89	0.87	0.54	0.85	1.17	1.45	1.09	–	–	–	–	–
Deferred Tax Liabilities	–	–	–	–	–	–	–	–	–	38	–	–
Total Liabilities	12	8.90	8.16	8.89	10.00	15	15	20	48	176	–	–
Total Debt	–	–	–	–	–	–	–	–	–	72	–	–
Common Stock	81	81	81	81	81	81	85	123	126	125	–	–
Additional Paid-In Capital	11	11	11	10	10	10	8.03	7.63	6.90	6.76	–	–
Retained Earnings	-74	-67	-66	-65	-66	-66	-63	-50	-55	-98	–	–
Shareholders' Equity	–	–	–	–	–	–	–	–	81	36	–	–
Noncontrolling Interest	–	–	–	–	–	–	–	–	–	2.09	–	–
Total Equity	13	21	20	21	18	19	27	84	81	38	4.46	-3.91
Total Liabilities & Equity	25	30	28	30	28	34	42	104	129	215	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin: 40.7%
Operating margin: –
Net margin: –
Return on equity, FY2025: –

Financial strength

Current ratio: 1.02
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 33.0%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –

Valuation ratios need the share price and fill in once daily prices are connected.